We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HALO icon
151
Halozyme
HALO
$9.66B
$27.9M 0.13%
487,131
+109,283
+29% +$6.27M
IEMG icon
152
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$27.9M 0.13%
485,547
-3,306
-0.7% -$179K
EVR icon
153
Evercore
EVR
$13.2B
$27.8M 0.13%
109,802
-7,878
-7% -$1.88M
OKE icon
154
Oneok
OKE
$56.4B
$27.5M 0.13%
301,945
-55,034
-15% -$4.79M
INTC icon
155
Intel
INTC
$462B
$27.4M 0.13%
1,168,687
-135,838
-10% -$3.39M
FIS icon
156
Fidelity National Information Services
FIS
$22.3B
$27.4M 0.13%
327,079
+91,332
+39% +$7.21M
AXTA icon
157
Axalta
AXTA
$7.22B
$27.3M 0.13%
754,539
-3,625
-0.5% -$127K
AZO icon
158
AutoZone
AZO
$50.2B
$27.1M 0.13%
8,589
+29
+0.3% +$89K
WAL icon
159
Western Alliance Bancorporation
WAL
$9.04B
$27M 0.13%
311,986
-4,669
-1% -$359K
MPWR icon
160
Monolithic Power Systems
MPWR
$65.8B
$26.7M 0.13%
28,885
– –
T icon
161
AT&T
T
$167B
$26.6M 0.13%
1,208,117
-71,128
-6% -$1.42M
ISRG icon
162
Intuitive Surgical
ISRG
$128B
$26.3M 0.13%
53,565
+2,655
+5% +$1.24M
KTB icon
163
Kontoor Brands
KTB
$4.74B
$26.2M 0.13%
320,727
-4,516
-1% -$322K
ABNB icon
164
Airbnb
ABNB
$87.2B
$25.9M 0.12%
204,633
-65,885
-24% -$8.54M
TSCO icon
165
Tractor Supply
TSCO
$16.7B
$25.6M 0.12%
440,125
-7,990
-2% -$429K
KLAC icon
166
KLA
KLAC
$266B
$25.3M 0.12%
326,680
+4,030
+1% +$316K
EW icon
167
Edwards Lifesciences
EW
$47.8B
$25.2M 0.12%
381,168
+21,505
+6% +$1.56M
CACI icon
168
CACI
CACI
$11B
$24.8M 0.12%
49,229
-699
-1% -$324K
SYK icon
169
Stryker
SYK
$129B
$24.6M 0.12%
68,150
-778
-1% -$269K
UTHR icon
170
United Therapeutics
UTHR
$26.3B
$24.6M 0.12%
68,605
+4,145
+6% +$1.4M
GILD icon
171
Gilead Sciences
GILD
$162B
$24.5M 0.12%
292,048
-34,711
-11% -$2.65M
FTDR icon
172
Frontdoor
FTDR
$5.1B
$24.3M 0.12%
506,328
+6,189
+1% +$268K
EXC icon
173
Exelon
EXC
$48.2B
$24M 0.11%
592,557
-52,390
-8% -$1.97M
DIS icon
174
Walt Disney
DIS
$168B
$24M 0.11%
249,083
-4,937
-2% -$454K
YUM icon
175
Yum! Brands
YUM
$40.7B
$23.8M 0.11%
170,678
-10,788
-6% -$1.43M
5 6
7
8 9

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.